CLEVELAND, Ohio (WOIO) - The Drug Enforcement Administration (DEA) is trying to keep prescription drugs from getting into the wrong hands. We looked into how they’re making sure pharmacies and doctors ...

Retirements Reported in DEA's DIVERSION as "DOGE CASUALTIES". "The DOJ admits the system is illegal, yet the DEA keeps using it to punish medical research," Boise stated. "This is a shadow court ...

Reform or dismantle the DEA's Diversion Control Division and transfer oversight of controlled-substance pharmaceuticals to the FDA or NIH, where science-not outdated drug war politics-guides policy.

Unjustified Delays: MMJ International Holdings claims that these officials have been instrumental in the multi-year delays of their application to cultivate pharmaceutical-grade marijuana, necessary ...

DEA Back to Training School, DEA Bureaucrat Blocks Science While Ignoring their Own TRAINING Manual. DEA Assistant Administrators and attorney needs a summer assignment, and MMJ BioPharma Cultivation ...

The DEA Diversion Control Problem: A Hidden Threat to U.S. Pharmaceutical Manufacturing ? Take the case of MMJ BioPharma Cultivation - despite submissions of FDA Investigational New Drug (IND) ...